A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease

NCT07403968 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda